Variant report

Variant	esv16714
Chromosome Location	chr7:3339551-3340091
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:22)
CpG islands
(count:61)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:22 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr7:3339959-3340991	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD2	chr7:3339627-3339800	HepG2	liver:	n/a	n/a
3	CTCF	chr7:3339980-3340130	GM12870	blood:	n/a	n/a
4	CTCF	chr7:3340000-3340150	SK-N-SH_RA	brain:	n/a	n/a
5	CTCF	chr7:3340040-3340190	HMEC	breast:	n/a	n/a
6	CTCF	chr7:3339276-3341235	SK-N-SH	brain:	n/a	chr7:3339295-3339303 chr7:3340483-3340496 chr7:3339382-3339390
7	CTCF	chr7:3339900-3340050	GM12873	blood:	n/a	n/a
8	HDAC2	chr7:3340091-3340976	MCF-7	breast:	n/a	n/a
9	MAX	chr7:3339823-3341087	MCF-7	breast:	n/a	chr7:3340556-3340566
10	MAX	chr7:3340024-3341114	A549	lung:	n/a	chr7:3340556-3340566
11	MAX	chr7:3339949-3341060	HepG2	liver:	n/a	chr7:3340556-3340566
12	MAX	chr7:3339893-3341102	HepG2	liver:	n/a	chr7:3340556-3340566
13	MAX	chr7:3339896-3341192	HepG2	liver:	n/a	chr7:3340556-3340566
14	MXI1	chr7:3339463-3341267	SK-N-SH	brain:	n/a	n/a
15	POLR2A	chr7:3339196-3339590	SK-N-MC	brain:	n/a	n/a
16	POLR2A	chr7:3339844-3341257	MCF-7	breast:	n/a	n/a
17	POLR2A	chr7:3339859-3340135	MCF-7	breast:	n/a	n/a
18	POLR2A	chr7:3339755-3340209	SK-N-MC	brain:	n/a	n/a
19	RAD21	chr7:3339138-3341287	SK-N-SH	brain:	n/a	chr7:3339313-3339327 chr7:3339322-3339335
20	SIN3AK20	chr7:3339879-3341185	PANC-1	pancreas:	n/a	n/a
21	SMC3	chr7:3339220-3341228	SK-N-SH	brain:	n/a	n/a
22	ZNF263	chr7:3339425-3341047	HEK293-T-REx	kidney:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:3339766-3339816	HPAEpiC	pulmonary alveolar:	n/a
2	chr7:3339766-3339816	SK-N-MC	brain:	n/a
3	chr7:3339766-3339816	H1-hESC	embryonic stem cell:	embryo
4	chr7:3339766-3339816	A549	lung:	n/a
5	chr7:3339766-3339816	BJ	skin:	n/a
6	chr7:3339766-3339816	PFSK-1	brain:	n/a
7	chr7:3339766-3339816	HCT-116	colon:	n/a
8	chr7:3339766-3339816	AG09319	gingival:	n/a
9	chr7:3339766-3339816	HEEpiC	esophagus:	n/a
10	chr7:3339766-3339816	MCF10A-Er-Src	breast:	n/a
11	chr7:3339766-3339816	GM19239	blood:	n/a
12	chr7:3339766-3339816	AG09309	skin:	n/a
13	chr7:3339766-3339816	NT2-D1	testis:	n/a
14	chr7:3339766-3339816	HRPEpiC	eye:	n/a
15	chr7:3339766-3339816	HCF	heart:	n/a
16	chr7:3339766-3339816	T-47D	breast:	n/a
17	chr7:3339766-3339816	GM12892	blood:	n/a
18	chr7:3339766-3339816	HIPEpiC	eye:	n/a
19	chr7:3339766-3339816	HRE	kidney:	n/a
20	chr7:3339766-3339816	HMEC	breast:	n/a
21	chr7:3339766-3339816	U87	brain:	n/a
22	chr7:3339766-3339816	IMR90	lung:	fetal
23	chr7:3339766-3339816	HEK293	kidney:	embryo
24	chr7:3339766-3339816	AG04449	skin:	fetal
25	chr7:3339766-3339816	GM06990	blood:	n/a
26	chr7:3339766-3339816	ovcar-3	ovarian:	n/a
27	chr7:3339766-3339816	AG10803	skin:	n/a
28	chr7:3339766-3339816	PANC-1	pancreas:	n/a
29	chr7:3339766-3339816	BE2_C	brain:	n/a
30	chr7:3339766-3339816	GM12891	blood:	n/a
31	chr7:3339766-3339816	ProgFib	skin:	n/a
32	chr7:3339766-3339816	NHDF-neo	bronchial:	n/a
33	chr7:3339766-3339816	K562	blood:	n/a
34	chr7:3339766-3339816	GM12878	blood:	n/a
35	chr7:3339766-3339816	RPTEC	kidney:	n/a
36	chr7:3339766-3339816	Hepatocyte	liver:	n/a
37	chr7:3339766-3339816	NHBE	bronchial:	n/a
38	chr7:3339766-3339816	HAEpiC	amniotic membrane:	n/a
39	chr7:3339766-3339816	CMK	blood:	n/a
40	chr7:3339766-3339816	SK-N-SH_RA	brain:	n/a
41	chr7:3339766-3339816	SAEC	small airway:	n/a
42	chr7:3339766-3339816	HL-60	blood:	n/a
43	chr7:3339766-3339816	Caco-2	colon:	n/a
44	chr7:3339766-3339816	ECC-1	luminal epithelium:	n/a
45	chr7:3339766-3339816	SKMC	muscle:	n/a
46	chr7:3339766-3339816	PrEC	prostate:	n/a
47	chr7:3339766-3339816	HRCEpiC	kidney:	n/a
48	chr7:3339766-3339816	HCM	heart:	n/a
49	chr7:3339766-3339816	Hela-S3	cervix:	n/a
50	chr7:3339766-3339816	LNCaP	prostate:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:3254030..3256348-chr7:3338235..3340171,2	MCF-7	breast:
2	chr7:3340063..3340822-chr7:3439252..3440083,5	MCF-7	breast:
3	chr7:3339718..3341766-chr7:3458306..3459954,2	K562	blood:

No data

Variant related genes	Relation type
SDK1	TF binding region
SDK1	CpG island
ENSG00000211544	chromatin interactions

Extended variants
information (count: 30 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:30 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs34469526	chr7:3339557-3339558	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs148276099	chr7:3339646-3339647	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs375731042	chr7:3339663-3339664	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs370645546	chr7:3339664-3339665	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs530678650	chr7:3339672-3339673	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs546771496	chr7:3339679-3339680	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs141384555	chr7:3339685-3339686	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs75246911	chr7:3339710-3339711	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs62440294	chr7:3339728-3339729	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs113849761	chr7:3339730-3339731	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs535007867	chr7:3339744-3339745	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs188114442	chr7:3339794-3339795	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs62440295	chr7:3339831-3339832	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs574887910	chr7:3339866-3339867	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs62437660	chr7:3339875-3339876	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs62437661	chr7:3339910-3339911	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs577495871	chr7:3339953-3339954	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs546105815	chr7:3339954-3339955	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs528248355	chr7:3339964-3339965	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs72576957	chr7:3339978-3339979	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs572894974	chr7:3339981-3339982	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs192688155	chr7:3339994-3339995	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs561302891	chr7:3340000-3340001	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs530447666	chr7:3340002-3340003	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs550427745	chr7:3340005-3340006	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs62437662	chr7:3340021-3340022	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs566712820	chr7:3340051-3340052	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs184531030	chr7:3340068-3340069	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs62437663	chr7:3340079-3340080	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs189274323	chr7:3340085-3340086	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Chordoma	21602918	CNVD
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Nasopharyngeal cancer	20548289	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
Spondylocostal dysostosis	21085971	CNVD
Mental retardation	17901693	CNVD
Heart disease	21282601	CNVD
Glioblastoma multiforme	22286061	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Colorectal cancer	21645411	CNVD
Intellectual disability	21811512	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:195 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:3334800-3339600	Weak transcription	Pancreas	Pancrea
2	chr7:3335000-3340000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr7:3337600-3339800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr7:3338600-3339600	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr7:3338600-3340200	Enhancers	NHDF-Ad	bronchial
6	chr7:3339000-3339800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr7:3339200-3339800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr7:3339200-3339800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr7:3339200-3340000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
10	chr7:3339400-3339600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
11	chr7:3339400-3339600	Enhancers	Primary neutrophils fromperipheralblood	blood
12	chr7:3339400-3339600	Flanking Active TSS	Adipose Nuclei	Adipose
13	chr7:3339400-3339600	Bivalent Enhancer	HepG2	liver
14	chr7:3339400-3339800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
15	chr7:3339400-3339800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr7:3339400-3339800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
17	chr7:3339400-3339800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr7:3339400-3339800	Bivalent Enhancer	Brain Germinal Matrix	brain
19	chr7:3339400-3340000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr7:3339400-3340000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
21	chr7:3339400-3340200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
22	chr7:3339400-3340200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
23	chr7:3339400-3340200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr7:3339400-3340200	Bivalent Enhancer	Fetal Thymus	thymus
25	chr7:3339400-3340600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
26	chr7:3339400-3340600	Bivalent Enhancer	Placenta	Placenta
27	chr7:3339600-3339800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
28	chr7:3339600-3339800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
29	chr7:3339600-3339800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
30	chr7:3339600-3339800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
31	chr7:3339600-3339800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
32	chr7:3339600-3339800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr7:3339600-3339800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr7:3339600-3339800	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
35	chr7:3339600-3339800	Enhancers	Fetal Heart	heart
36	chr7:3339600-3339800	Enhancers	Pancreas	Pancrea
37	chr7:3339600-3339800	Enhancers	Right Ventricle	heart
38	chr7:3339600-3340000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
39	chr7:3339600-3340000	Enhancers	H9 Cell Line	embryonic stem cell
40	chr7:3339600-3340000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
41	chr7:3339600-3340000	Enhancers	Breast Myoepithelial Primary Cells	Breast
42	chr7:3339600-3340000	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
43	chr7:3339600-3340000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
44	chr7:3339600-3340000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
45	chr7:3339600-3340000	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
46	chr7:3339600-3340000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr7:3339600-3340000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr7:3339600-3340000	Bivalent Enhancer	Adipose Nuclei	Adipose
49	chr7:3339600-3340000	Bivalent Enhancer	Fetal Intestine Small	intestine
50	chr7:3339600-3340000	Bivalent Enhancer	Stomach Smooth Muscle	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links